Leslie A. Geer
- Pharmacology top 10%
- Pharmacology top 5%
- Infectious Diseases
- Virology top 10%
- Biochemistry top 10%
- Co-authors
- Rita A. HalpinCatherine Z. MatthewsEric WoolfKenneth C. LasseterDonghui CuiKamlesh P. VyasNancy AgrawalKeith Gottesdiener
- Topics
- Inflammatory mediators and NSAID effects (6 papers)Pharmacogenetics and Drug Metabolism (5 papers)Eicosanoids and Hypertension Pharmacology (4 papers)
- Cited by
- VirologyPharmacology
- Journals
- Journal of Controlled ReleaseAntimicrobial Agents and ChemotherapyDrug Metabolism and Disposition
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Leslie A. Geer
10 papers receiving 321 citations
Peers
Comparison fields: 5 of 76
- Pharmacology 142
- Pharmacology 93
- Infectious Diseases 63
- Virology 55
- Biochemistry 47
Countries citing papers authored by Leslie A. Geer
This map shows the geographic impact of Leslie A. Geer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie A. Geer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie A. Geer more than expected).
Fields of papers citing papers by Leslie A. Geer
This network shows the impact of papers produced by Leslie A. Geer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie A. Geer. The network helps show where Leslie A. Geer may publish in the future.
Co-authorship network of co-authors of Leslie A. Geer
This figure shows the co-authorship network connecting the top 25 collaborators of Leslie A. Geer. A scholar is included among the top collaborators of Leslie A. Geer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie A. Geer. Leslie A. Geer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 53 | |
| 2 | 43 | |
| 3 | Pre-treatment with Depo-Provera modifies the pharmacokinetics of CMPD167 in rhesus macaques following vaginal ring administration | 4 |
| 4 | 32 | |
| 5 | 19 | |
| 6 | 22 | |
| 7 | 64 | |
| 8 | 38 | |
| 9 | Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniques. | 24 |
| 10 | 46 |
About Leslie A. Geer
Leslie A. Geer is a scholar working on Pharmacology, Biochemistry and Pharmacology, having authored 10 papers that have together received 345 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Virology (55 citations), Pharmacology (93 citations) and Pharmacology (142 citations). Leslie A. Geer has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Rita A. Halpin, Catherine Z. Matthews, Eric Woolf, Kenneth C. Lasseter, Donghui Cui, Kamlesh P. Vyas, Nancy Agrawal, Keith Gottesdiener, Patrick Larson and Karl Malcolm. Their work appears in journals such as Journal of Controlled Release, Antimicrobial Agents and Chemotherapy and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.